Hong-Wu Xin

2.1k total citations · 1 hit paper
52 papers, 1.6k citations indexed

About

Hong-Wu Xin is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Hong-Wu Xin has authored 52 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 19 papers in Molecular Biology and 13 papers in Cancer Research. Recurrent topics in Hong-Wu Xin's work include Cancer Cells and Metastasis (14 papers), Virus-based gene therapy research (10 papers) and Herpesvirus Infections and Treatments (6 papers). Hong-Wu Xin is often cited by papers focused on Cancer Cells and Metastasis (14 papers), Virus-based gene therapy research (10 papers) and Herpesvirus Infections and Treatments (6 papers). Hong-Wu Xin collaborates with scholars based in China, United States and Singapore. Hong-Wu Xin's co-authors include Zhaowu Ma, Jun-Ting Cheng, Yingying Wang, Ying Xiang, Xiaochun Peng, Xianwang Wang, Shuzhong Cui, Wen-Qi Cai, Lingzhi Wang and Gautam Sethi and has published in prestigious journals such as Blood, Molecular and Cellular Biology and Cancer Research.

In The Last Decade

Hong-Wu Xin

49 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Dendritic cell biology and its role in tumor immunotherapy

2020 327 citations Yingying Wang, Ying Xiang et al. profile →

Peers

Countries citing papers authored by Hong-Wu Xin

Since Specialization

Citations

This map shows the geographic impact of Hong-Wu Xin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hong-Wu Xin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hong-Wu Xin more than expected).

Fields of papers citing papers by Hong-Wu Xin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hong-Wu Xin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hong-Wu Xin. The network helps show where Hong-Wu Xin may publish in the future.

Co-authorship network of co-authors of Hong-Wu Xin

This figure shows the co-authorship network connecting the top 25 collaborators of Hong-Wu Xin. A scholar is included among the top collaborators of Hong-Wu Xin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hong-Wu Xin. Hong-Wu Xin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Safety and Efficacy of Endoscopic Retrograde Appendicitis Therapy for Pediatric Patients: A Single-Center Retrospective Study in Chinese Children 2025 ·The American Journal of Gastroenterology ·(unknown), Saif Ullah, Deliang Li, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Hong-Wu Xin, Bing-Rong Liu	1
2	Gut microbiota plays a significant role in gout 2024 ·Journal of Medical Microbiology ·Zhipeng Feng, Xiaoyan Wang, Hong-Yi Xin, (unknown), Hongyu Huang, Qiang Xin, Xi-He Zhang, Hong-Wu Xin	3
3	Recent Advances on the Molecular Mechanism and Clinical Trials of Venous Thromboembolism 2023 ·Journal of Inflammation Research ·(unknown), Hong-Yi Xin, (unknown), (unknown), Fuqing Wu, Zhipeng Feng, (unknown), Xi-He Zhang, Hong-Wu Xin, (unknown)	7
4	RNA nanotechnology: A new chapter in targeted therapy 2023 ·Colloids and Surfaces B Biointerfaces ·(unknown), Yingying Meng, Yifan Liu, (unknown), Hong-Wu Xin, Xiaochun Peng, (unknown)	10
5	Oncolytic virotherapy evolved into the fourth generation as tumor immunotherapy 2023 ·Journal of Translational Medicine ·Xianwang Wang, (unknown), (unknown), (unknown), Wen-Qi Cai, (unknown), Qiang Xin, Xiaoqing Liu, Jingang Gui, Hong-Yi Xin, Hong-Wu Xin	17
6	Bioinformatics analyses suggest that mutations in COL12A1 and its miRNAs promote stomach adenocarcinoma via loss of COL12A1 suppression 2023 ·ONCOLOGIE ·Qiang Xin, Yanlong Zhao, (unknown), Hong-Yi Xin, (unknown), Hong-Wu Xin, Xiaoyan Wang, Yingying Wang, Xiulan Su	1
7	Multifunctional Non-Coding RNAs Mediate Latent Infection and Recurrence of Herpes Simplex Viruses 2021 ·Infection and Drug Resistance ·Ying Zhang, Lisi Zeng, Juan Wang, Wen-Qi Cai, (unknown), (unknown), Xiaochun Peng, Zhaowu Ma, Ying Xiang, Shuzhong Cui, Hong-Wu Xin	5
8	Bioinformatics Analysis Revealed Potential Tumor Suppressors (KLF4/CGN), Oncogenes (SHH/LIF) and Biomarkers of Asian Stomach Adenocarcinoma 2021 ·Yang Zhou, Yingying Wang, Jun-Ting Cheng, Ying Zhang, Wen-Qi Cai, (unknown), (unknown), Qi Huang, Xiaochun Peng, Hong-Wu Xin	1
9	Gut microbiota homeostasis restoration may become a novel therapy for breast cancer 2021 ·Investigational New Drugs ·Zhipeng Feng, Hong-Yi Xin, Zewei Zhang, Chenguang Liu, Zheng Yang, Hua You, Hong-Wu Xin	14
10	Mechanisms and Clinical Trials of Hepatocellular Carcinoma Immunotherapy 2021 ·Frontiers in Genetics ·(unknown), Yuming Wang, (unknown), (unknown), Fuqing Wu, (unknown), Xi-He Zhang, Hong-Wu Xin	30
11	The Latest Battles Between EGFR Monoclonal Antibodies and Resistant Tumor Cells 2020 ·Frontiers in Oncology ·Wen-Qi Cai, Lisi Zeng, Lifeng Wang, Yingying Wang, Jun-Ting Cheng, Ying Zhang, (unknown), Yang Zhou, (unknown), Xianwang Wang, Xiaochun Peng, Ying Xiang, Zhaowu Ma, Shuzhong Cui, Hong-Wu Xin	127
12	Target Deconvolution of a Multikinase Inhibitor with Antimetastatic Properties Identifies TAOK3 as a Key Contributor to a Cancer Stem Cell–Like Phenotype 2019 ·Molecular Cancer Therapeutics ·Yansong Bian, Yaroslav Teper, Lesley A. Mathews Griner, Taylor Aiken, Vivek Shukla, Rajarshi Guha, Paul Shinn, Hong-Wu Xin, Holger Pflicke, Astin S. Powers, Dandan Li, Jian‐kang Jiang, Paresma Patel, Steven A. Rogers, Jeffrey Aubé, Marc Ferrer, Craig J. Thomas, Udo Rudloff	19
13	The expanding roles of long non-coding RNAs in the regulation of cancer stem cells 2019 ·The International Journal of Biochemistry & Cell Biology ·Zhaowu Ma, Yingying Wang, Hong-Wu Xin, Lingzhi Wang, Frank Arfuso, Arun Dharmarajan, Alan Prem Kumar, Hong Wang, Feng Ru Tang, Sudha Warrier, Vinay Tergaonkar, Gautam Sethi	78
14	Loss of PDPK1 abrogates resistance to gemcitabine in label-retaining pancreatic cancer cells 2018 ·BMC Cancer ·Dandan Li, John E. Mullinax, Taylor Aiken, Hong-Wu Xin, Gordon Wiegand, Andrew J. Anderson, Snorri S. Thorgeirsson, Itzhak Avital, Udo Rudloff	17
15	CRISPR/Cas9 genome editing technology significantly accelerated herpes simplex virus research 2018 ·Cancer Gene Therapy ·Dong Wang, Xianwang Wang, Xiaochun Peng, Ying Xiang, (unknown), Yingying Wang, Lin Chen, (unknown), (unknown), Jiafu Ji, Zhaowu Ma, Chengbin Li, Hong-Wu Xin	41
16	Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in treatment of gastric cancer with peritoneal carcinomatosis 2017 ·Chinese Journal of Cancer Research ·(unknown), Yan‐Gao Man, Alexander Stojadinovic, Hong-Wu Xin, Itzhak Avital	15
17	Wnt and the Cancer Niche: Paracrine Interactions with Gastrointestinal Cancer Cells Undergoing Asymmetric Cell Division 2013 ·Journal of Cancer ·Hong-Wu Xin, (unknown), Satyajit Ray, (unknown), Tomotake Koizumi, Gordon Wiegand, Danielle M. Hari, John E. Mullinax, Kshama Jaiswal, Susan H. Garfield, Alexander Stojadinovic, Udo Rudloff, Snorri S. Thorgeirsson, Itzhak Avital	18
18	Establishment of Human Ultra-Low Passage Colorectal Cancer Cell Lines Using Spheroids from Fresh Surgical Specimens Suitable for In Vitro and In Vivo Studies 2012 ·Journal of Cancer ·Satyajit Ray, Russell C. Langan, John E. Mullinax, Tomotake Koizumi, Hong-Wu Xin, Gordon Wiegand, (unknown), Alexander Stojadinovic, Snorri S. Thorgeirsson, Udo Rudloff, Itzhak Avital	16
19	A Pilot Study Assessing the Potential Role of non-CD133 Colorectal Cancer Stem Cells as Biomarkers 2012 ·Journal of Cancer ·Russell C. Langan, John E. Mullinax, Satyajit Ray, Manish T. Raiji, Nicholas P. Schaub, Hong-Wu Xin, Tomotake Koizumi, Seth M. Steinberg, Andrew J. Anderson, Gordon Wiegand, Donna Butcher, Miriam R. Anver, Anton J. Bilchik, Alexander Stojadinovic, Udo Rudloff, Itzhak Avital	48
20	Isolation of Live Label-Retaining Cells and Cells Undergoing Asymmetric Cell Division via Nonrandom Chromosomal Cosegregation from Human Cancers 2011 ·Stem Cells and Development ·Danielle M. Hari, Hong-Wu Xin, Kshama Jaiswal, Gordon Wiegand, (unknown), (unknown), (unknown), Tomotake Koizumi, Satyajit Ray, Susan H. Garfield, Snorri S. Thorgeirsson, Itzhak Avital	32

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact